The data from DFS analysis (Figure 2(b)) indicated that high expression of COPB2 was interrelated with poor prognosis of TCGA cases with ACC (P = 0.012), BLCA (P = 0.015), LGG (P = 0.03), MESO (P = 0.028), and PAAD (P = 0.044) tumors. Here, COPB2 is linked to adrenal cortex carcinoma.